If you are:
Only When Necessary: INCREASED FETAL ABNORMALITIES/TOXICITY IN ANIMAL STUDIES W/DOSES SIMILAR TO MRHD
Precaution: LIMITED DATA SUGGEST AMOUNT EXCRETED IS MINIMAL; ADVERSE EFFECTS UNLIKELY
An adult over 60:
management or monitoring precaution: Renal-Reduced clearance results in 30-60% higher plasma levels. Titrate dose slowly. Start at one-half the usual starting dose for CrCL< 30mL/minute. Neuro/Psych-Can cause significant cognitive impairment, somnolence and gait disturbances that may increase fall risk. Metabolic-Clinically significant hyponatremia occurs more frequently during the first 3 months of treatment. Monitor serum sodium.
Giving oxcarbazepine tablet to a child under 12:
management or monitoring precaution: Not indicated in pediatrics under age 6 years. Dose form inappropriate for young children.
management or monitoring precaution: Not indicated in pediatrics under age 2 years. Increased incidence of infection in younger children.